The offices of Drug Store News will be closed on Sept. 7 for Labor Day. We will resume publishing on Sept. 8. We wish you and your family a happy and safe holiday!
AstraZeneca on Thursday announced that the Food and Drug Administration approved Brilinta (ticagrelor) tablets at a 60 mg dose for patients with a history of heart attack beyond the first year.
Retail analytic company RetailNext on Friday announced its monthly Retail Performance Pulse, showing a 7.3% year-over-year decrease in sales and a 9.9% decline in traffic at physical stores for August.
Pfizer said that the transaction has strengthened the company’s branded and generics portfolio, particularly when it comes to biosimilars.
“What’s in greatest demand today isn’t more data, but synthesis — understanding what’s next, crossing boundaries and being able to combine different pieces into an interesting new whole.” That’s what Dan Mack, managing director of the Mack Elevation Forum, asked attendees to do at Friday’s exclusive, one-day summit co-hosted by Mack Elevation Forum and Drug Store News at Kevin Taylor’s at the Opera House in Denver.
In the next several years, millennials will represent 30% of dollars coming into consumer package good companies. As a result, its up to brand marketers to figure out how to reach millennial consumers.